Editorial commnet from Dr. Ishizuka to periurethral injection of autologous adipose-derived regenerative cells for the treatment of male stress incontinence: report of three initial cases.
Editorial commnet from Dr. Ishizuka to periurethral injection of autologous adipose-derived regenerative cells for the treatment of male stress incontinence: report of three initial cases.
复制标题
Ishizuka 博士关于尿道周围注射自体脂肪再生细胞治疗男性压力性尿失禁的编辑通讯：三个初始病例的报告。
DOI：
10.1111/j.1442-2042.2012.03145.x
复制
发表时间：
2013
期刊：
影响因子：
--
通讯作者：
Ishizuka O
中科院分区：
文献类型：
--
作者：
Satoko Kojima;Takeshi Chiyomaru;Hideki Enokida;Kazumori Kawakami;Hirofumi Yoshino,Nijiro Nohata3;Miki Fuse;Tomohiko Ichikawa;Yukio Naya;Masayuki Nakagawa;and Naohiko Seki;Ishizuka O
作者讨论了N. Wada及其同事关于E系列前列腺素（EP）1受体拮抗剂在环磷酰胺（CTX）诱导的膀胱炎大鼠中的作用。作者提到了前列腺素E2（PGE2）控制排尿的机制，如由速激肽受体介导的机制。他补充说，速激肽受体拮抗剂未应用于泌尿系统疾病治疗的临床领域。
The author discusses the study conducted by N. Wada and colleagues regarding the roles of E-series prostaglandin (EP) 1 receptor antagonist in cyclophosphamide (CYP)-induced cystitis rats. The author mentions the mechanisms of prostaglandin E2 (PGE2) for micturition control such as one mediated by tachykinin receptors. He adds that tachykinin receptor antagonists are not applied in the clinical field for urinary disorders treatment.